Company Filing History:
Years Active: 2020
Title: John Linley: Innovator in Neuropathic Pain Treatment
Introduction
John Linley is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on innovative solutions for treating neuropathic pain and other medical conditions.
Latest Patents
John Linley holds a patent for "P2X4 antibodies and uses thereof." This invention provides antibodies that specifically bind to a P2X4 polypeptide and modulate P2X4 channel activity. It includes recombinant P2X4 polypeptides and methods for generating such polypeptides. Additionally, it encompasses compositions and methods for generating anti-P2X4 antibodies, as well as methods of using these antibodies for the treatment of neuropathic pain and other indications. He has 1 patent to his name.
Career Highlights
John Linley is currently employed at MedImmune Limited, where he continues to advance his research and development efforts. His work at the company has positioned him as a key player in the biotechnology sector, contributing to innovative treatments that address significant health challenges.
Collaborations
Some of his notable coworkers include Wendy A. Williams and Clare Jones. Their collaborative efforts have further enhanced the research environment at MedImmune Limited, fostering innovation and development in therapeutic solutions.
Conclusion
John Linley's contributions to the field of biotechnology, particularly through his patent on P2X4 antibodies, highlight his commitment to advancing medical science. His work has the potential to significantly impact the treatment of neuropathic pain and improve patient outcomes.